This application is for a Training Program in the Pharmacological Sciences to support nine outstanding pre- doctoral students who will be working for a Ph.D. in the Departments of Pharmacology, Chemistry, Biochemistry &Molecular Genetics, Molecular Physiology &Biological Physics or Microbiology. Their research emphasis will be on scientific problems relevant to the biochemical and physiological effects of drugs and their mechanisms of action. The trainees will be selected primarily from among students entering the University of Virginia via the Molecular Medicine umbrella program and secondarily from students enrolled in the Medical Scientist Training Program or the Department of Chemistry who are receiving training in problems of pharmacologic relevance. The 35 faculty mentors are drawn from the Departments listed above as well as the Department of Medicine with an emphasis on individuals who collaborate with Pharmacology Department faculty. These faculty all direct robust research programs and collectively have trained hundreds of students and fellows. The academic units participating in this program are well equipped to provide state of the art re- search training in their respective disciplines. In addition, core facilities for advanced technologies such as small animal imaging, gene chip/microarrays, mass spectrometry, cell sorting, confocalimaging, computational support, etc.are available for enhancement of the research training of participating students. The goal of this Training Program is to prepare selected individuals for careers in basic research and teaching relevant to problems of pharmacologic importance.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007055-38
Application #
8292043
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (TG))
Program Officer
Okita, Richard T
Project Start
1985-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
38
Fiscal Year
2012
Total Cost
$236,722
Indirect Cost
$14,858
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan et al. (2018) cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med 24:50-61
Olmez, Inan; Love, Shawn; Xiao, Aizhen et al. (2018) Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha. Neuro Oncol 20:192-202
Campbell, Sean T; Franks, Caroline E; Borne, Adam L et al. (2018) Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells. Mol Pharmacol 94:1246-1255
Meher, Akshaya K; Spinosa, Michael; Davis, John P et al. (2018) Novel Role of IL (Interleukin)-1? in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms. Arterioscler Thromb Vasc Biol 38:843-853
Shin, Myungsun; Franks, Caroline E; Hsu, Ku-Lung (2018) Isoform-selective activity-based profiling of ERK signaling. Chem Sci 9:2419-2431
McCloud, Rebecca L; Franks, Caroline E; Campbell, Sean T et al. (2018) Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics. Biochemistry 57:231-236
Serbulea, Vlad; Upchurch, Clint M; Ahern, Katelyn W et al. (2018) Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism. Mol Metab 7:23-34
Narahari, Adishesh K; Mehaffey, J Hunter; Hawkins, Robert B et al. (2018) Surgeon Scientists Are Disproportionately Affected by Declining NIH Funding Rates. J Am Coll Surg 226:474-481
Schappe, Michael S; Szteyn, Kalina; Stremska, Marta E et al. (2018) Chanzyme TRPM7 Mediates the Ca2+ Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation. Immunity 48:59-74.e5
Schweitzer, George G; Collier, Sara L; Chen, Zhouji et al. (2018) Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice. FASEB J :fj201800361R

Showing the most recent 10 out of 93 publications